Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Cue Biopharma (CUE) over the last 9 years, with Q3 2025 value amounting to $667000.0.

  • Cue Biopharma's Other Non-Current Assets fell 7520.45% to $667000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $667000.0, marking a year-over-year decrease of 7520.45%. This contributed to the annual value of $2.0 million for FY2024, which is 2732.34% down from last year.
  • According to the latest figures from Q3 2025, Cue Biopharma's Other Non-Current Assets is $667000.0, which was down 7520.45% from $2.0 million recorded in Q2 2025.
  • Cue Biopharma's 5-year Other Non-Current Assets high stood at $3.8 million for Q2 2022, and its period low was $667000.0 during Q3 2025.
  • Over the past 5 years, Cue Biopharma's median Other Non-Current Assets value was $2.7 million (recorded in 2023), while the average stood at $2.6 million.
  • As far as peak fluctuations go, Cue Biopharma's Other Non-Current Assets soared by 4497.9% in 2022, and later plummeted by 7520.45% in 2025.
  • Cue Biopharma's Other Non-Current Assets (Quarter) stood at $2.7 million in 2021, then grew by 14.52% to $3.1 million in 2022, then decreased by 13.67% to $2.7 million in 2023, then fell by 27.32% to $2.0 million in 2024, then plummeted by 65.88% to $667000.0 in 2025.
  • Its Other Non-Current Assets stands at $667000.0 for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.